"As a precautionary measure, Sanofi will conduct a voluntary recall of Zantac."
Image by Pexels from Pixabay
Sanofi recalls popular heartburn drug in US and Canada
(Agence France-Presse) - October 19, 2019 - 11:40am

WASHINGTON, United States — French pharmaceutical giant Sanofi on Friday said it was recalling over-the-counter heartburn medication Zantac in the United States and Canada after a possible carcinogen was detected.

"As a precautionary measure, Sanofi will conduct a voluntary recall of Zantac," the company said in a statement.

"This recall is being taken due to possible contamination with a nitrosamine impurity called N-nitrosodimethylamine (NDMA)," which the World Health Organizations classifies as a possible carcinogen.

The decision followed reports from the US Food and Drug Administration and Health Canada released last month "alerting that some ranitidine medicines, including Zantac OTC, could contain NDMA at low levels and asked manufacturers to conduct testing," Sanofi said, adding that "evaluations are ongoing."

Large pharmacy chains in the US like CVS and Walgreens have already taken Zantac off their shelves, local media reported.

  • Latest
  • Trending
Are you sure you want to log out?

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

or sign in with